Exploring risks for MRSA infection A tale of two studies

Size: px
Start display at page:

Download "Exploring risks for MRSA infection A tale of two studies"

Transcription

1 CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Exploring risks for MRSA infection A tale of two studies 2 March 2012 A group of bacteria called S. aureus (Staphylococcus aureus ) are commonly found on the skin of animals and people. Specifically, these bacteria can be found in 25% to 50% of healthy people in at least one of these places: inside the nostrils the skin between the anus and genitals genitals armpits mouth and throat For most people, exposure to S. aureus arises because of touching an infected surface or object. As people frequently touch parts of their body, especially the face, it is easy to imagine how S. aureus can spread from a contaminated surface to a person. Good hygiene and hand washing are important to help restrict the spread of S. aureus because attempts at creating a potent vaccine against this germ have not been successful. Further information on preventing S. aureus infections appears later in this CATIE News bulletin. In otherwise-healthy humans, S. aureus lives on the skin and does not cause disease. When bacteria are resident on or inside the body and not causing harm, researchers say that the person has been colonized by these bacteria. However, because of cuts, punctures, wounds and abrasions, S. aureus can sometimes penetrate the skin. Once inside the skin, S. aureus can cause inflammation, boils and abscesses. In severe cases, the infection can affect and damage large areas of skin and other organs, causing serious complications. Some strains of S. aureus have become resistant to an antibiotic called methicillin and these strains are called MRSA methicillin-resistant S. aureus. Two kinds of MRSA MRSA was originally a problem restricted to hospitalized patients. However, well-recognized cases of communityacquired MRSA have occurred. It is not just the location (health-care facility vs. community) that distinguishes these two types of MRSA. Health-care-associated MRSA has been associated with the following: surgery living in a nursing home having a catheter Health-care-associated MRSA can cause pneumonia. In contrast, community-acquired MRSA is mostly associated with skin and soft tissue infections, infection of the lining of the heart, and, in some cases, a rapidly worsening form of pneumonia. The rest of this report focuses on community-acquired MRSA. Who is at risk? Some outbreaks of community-acquired MRSA have affected people who may have been exposed to MRSA by close personal contact with other people in the following facilities:

2 military barracks prisons athletic facilities Based on years of research, scientists have found that the following groups are at increased risk for S. aureus infection: men infants and young children elderly people people with severely damaged kidneys who need artificial blood filtration (dialysis) diabetics people receiving chemotherapy for cancer people with rheumatoid arthritis people who use street drugs people who abuse alcohol In most of the above cases, there is the issue of a weakened immune system from several potential causes. For instance, in both the very young and the elderly, the immune system is not at its prime and both populations are at increased risk for infections. Excess intake of alcohol and exposure to street drugs can also weaken the immune system. As weakened immunity plays a role in a person s susceptibility to infections, it should not be surprising that there have been reports of MRSA causing complications in HIV-positive people, whose immune systems are also weakened because of HIV infection. In separate studies in different American cities (Chicago and San Diego) two teams of researchers have investigated MRSA in the community and possible risk factors among HIV-positive people. In the Chicago study, researchers found that factors such as a history of being imprisoned and living in a neighbourhood with a relatively high proportion of former prison inmates seemed to confer a far greater risk for MRSA than being HIV positive. In the second study, researchers in San Diego analysed data from many studies of MRSA among HIV-positive people. Their analysis suggests that engagement in high-risk behaviours seems to put some HIV-positive people at increased risk for MRSA. Chicago Prisons, shelter and geography Researchers in Chicago recently investigated MRSA among 601 participants (76% were HIV positive). Participants were recruited from a clinic that provided care for HIV-positive women and from a clinic that provided care for people recently released from prison. Analysis of swabs taken from the nostrils of participants revealed that HIV-positive people were nearly three times as likely to have MRSA as HIV-negative people. However, when researchers took many factors into account such as whether participants were homeless or lived in a hostel for homeless people or in a shelter for people undergoing drug withdrawal or in public housing or a mental health facility HIV infection was no longer a significant factor for having MRSA. According to the team, this finding suggests that community exposures may be more important for predicting MRSA colonization than HIV status in certain populations. Participants who lived in neighbourhoods where there were relatively many former prison inmates seemed to be at increased risk for having been colonized by MRSA. Indeed, the Chicago team found that 71% of people in its study who had been colonized by MRSA had formerly been imprisoned. The team theorized that HIV status may be a [signifier] for exposure to high-risk social networks rather than being the major factor contributing to the high colonization and infection burden. The specific factors that occur in prison that could place people at risk for MRSA colonization were not explored in the Chicago study. San Diego Links to behaviour

3 A research team in San Diego conducted a review of scientific literature published between 1996 and January 2011 on MRSA and HIV. The review found that HIV-positive people are at increased risk for colonization by MRSA. It is important to note that while many people are colonized by S. aureus (some of which is MRSA), most people, including HIV-positive people, will not develop infections unless they have risk factors for MRSA. To gain an understanding of possible risk factors, the San Diego researchers scoured the scientific literature for MRSA risk factors among HIV-positive people. They found that studies linked a heightened risk for MRSA colonization to known risk factors such as weakened immunity (low CD4+ cell counts), recent hospitalization, recent use of antibiotics and having chronic skin disease. When the researchers focused on recent research, they found that MRSA colonization was linked to certain highrisk behaviours, particularly among HIV-positive men who have sex with men (MSM) regardless of age who engaged in the following: unprotected anal intercourse multiple sexual partners recent diagnosis of a sexually transmitted infection (including syphilis) visiting a public bathhouse or sauna substance use (including crystal meth) Exactly how unprotected sex can help spread MRSA deserves further study, but here is one possibility: MRSA can live in the intestine and anything inserted into the anus penises, fingers, sex toys may become contaminated with these bacteria. The widespread availability of potent combination therapy for HIV, commonly called ART or HAART, has meant that there are now less people with HIV who have severely weakened immune systems compared to the time before ART was available. Therefore, behavioural factors (rather than low CD4+ cell counts) likely play a more prominent role in the spread of and risk for MRSA infections today. Types of MRSA infections among HIV-positive people The literature review revealed that abscesses were the most common type of skin and soft tissue infection caused by MRSA among HIV-positive people. According to the research team, such infections were usually mild and associated with low rates of complications. Most of these infections were in the lower extremities arms and hands, feet and legs. However, infections could occur elsewhere and recent reports suggest that MRSA in the anogenital area is increasing. The researchers suggest that this is associated with high-risk behaviours (as previously described). More serious MRSA infections such as those that had spread to the bloodstream tended to occur among people who had one or more of the following risk factors: injected street drugs severe kidney dysfunction low CD4+ cell counts (less than 200 cells) The research team also found that MRSA could cause other complications, such as infecting the lining of the brain and the heart, bones, the sinuses and vital organs (liver, lungs and kidneys). However, such serious infections were uncommon particularly among people using ART. Trends in MRSA Among HIV-negative people, MRSA infections now seem to be less common both in health-care settings and in the community than they were several years ago. A similar general trend appears to be occurring among HIV-positive people. Preventing MRSA

4 Several steps can be taken to reduce the risk of exposure to MRSA: Practice good hygiene wash hands regularly with warm water and soap or use an alcohol-based hand sanitizer. Shower with soap after sexual contact. Avoid sharing personal items such as towels, washcloths, razors, clothes (including uniforms) and sex toys. Cover wounds and avoid contact with other people s wounds or bandages. Reduce illicit substance use and seek professional help for quitting. See a physician for accurate advice about treating skin infections. The San Diego teams calls for further research to evaluate the impact of high-risk behaviours on MRSA colonization and infection. High-risk behaviour is a relatively broad term but can include the following: engaging in unprotected intercourse with or without multiple partners engaging in substance use (not only injecting drugs but inhaling or otherwise ingesting street drugs, as these weaken the immune system) Future research on MRSA risk will hopefully also explore the following issues: clinical trials with antibiotics to decolonize large groups of people in a community studies that take swabs not only from inside the nostrils but from other body parts such as the ano-genital region the impact of ART on MRSA colonization risk in HIV-positive people Although reports of MRSA infections among HIV-positive people in high-income countries appear to be waning, overall, the risk of MRSA colonization and infection is still greater for HIV-positive people than it is for HIV-negative people. Therefore, further research focusing on the immune system, use of antibiotics and behaviour is necessary to understand why this is the case. Until the results of such research become available, the San Diego researchers urge HIV-positive people to reduce their risk of acquiring MRSA by engaging in good hygiene practices, taking ART and minimizing episodes of unprotected sex and substance use. Resources MRSA Fact Sheets from the Public Health Agency of Canada MRSA facts from ministère de la Santé et des Services sociaux Québec Personal MRSA prevention tips from the American Centers for Disease Control and Prevention New York City Department of Health and Mental Hygiene REFERENCES: Sean R Hosein 1. Lowy FD. Staphylococcal Infections. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison s Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; Chapter Que Y-A and Moreillo P. Staphylococcus aureus (including Staphylococcal toxic shock). In: Mandell GL, Bennett JE and Dolin R, editors. Principles and Practice of Infectious Diseases. Seventh ed. Philadelphia: Elsevier; p Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clinical Infectious Diseases Oct 1;39(7): Popovich KJ, Smith KY, Khawcharoenporn T, et al. Community-associated methicillin-resistant Staphylococcus aureus colonization in high-risk groups of HIV-infected patients. Clinical Infectious Diseases. 2012; in press. 5. Proctor RA. Challenges for a universal Staphylococcus aureus vaccine. Clinical Infectious Diseases. 2012; in press. 6. Shadyab A, Crum-Cianflone N. Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-

5 infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Medicine. 2012; in press. 7. Crum-Cianflone NF, Shadyab AH, Weintrob A, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) colonization with high-risk sexual behaviors in persons infected with human immunodeficiency virus (HIV). Medicine (Baltimore) Nov;90(6): Szumowski JD, Wener KM, Gold HS, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clinical Infectious Diseases Jul 1;49(1): Lee NE, Taylor MM, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clinical Infectious Diseases May 15;40(10): Cohen AL, Shuler C, McAllister S, et al. Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerging Infectious Diseases Nov;13(11): Antoniou T, Devlin R, Gough K, et al. Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization in men who have sex with men. International Journal of STD & AIDS Mar;20(3):180-3.

6 Produced By: 555 Richmond Street West, Suite 505, Box 1104 Toronto, Ontario M5V 3B1 Canada Phone: Toll-free: Fax: Charitable registration number: RR Disclaimer Decisions about particular medical treatments should always be made in consultation with a qualified medical practitioner knowledgeable about HIV- and hepatitis C-related illness and the treatments in question. CATIE provides information resources to help people living with HIV and/or hepatitis C who wish to manage their own health care in partnership with their care providers. Information accessed through or published or provided by CATIE, however, is not to be considered medical advice. We do not recommend or advocate particular treatments and we urge users to consult as broad a range of sources as possible. We strongly urge users to consult with a qualified medical practitioner prior to undertaking any decision, use or action of a medical nature. CATIE endeavours to provide the most up-to-date and accurate information at the time of publication. However, information changes and users are encouraged to ensure they have the most current information. Users relying solely on this information do so entirely at their own risk. Neither CATIE nor any of its partners or funders, nor any of their employees, directors, officers or volunteers may be held liable for damages of any kind that may result from the use or misuse of any such information. Any opinions expressed herein or in any article or publication accessed or published or provided by CATIE may not reflect the policies or opinions of CATIE or any partners or funders. Information on safer drug use is presented as a public health service to help people make healthier choices to reduce the spread of HIV, viral hepatitis and other infections. It is not intended to encourage or promote the use or possession of illegal drugs. Permission to Reproduce This document is copyrighted. It may be reprinted and distributed in its entirety for non-commercial purposes without prior permission, but permission must be obtained to edit its content. The following credit must appear on any reprint: This information was provided by CATIE (the Canadian AIDS Treatment Information Exchange). For more information, contact CATIE at CATIE Production of this content has been made possible through a financial contribution from the Public Health Agency of Canada. Available online at:

Superbug increasing among HIV positive people

Superbug increasing among HIV positive people CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Superbug increasing among HIV positive people 24 September 2007 Bacteria are a common source of problems, causing a variety of infections,

More information

Understanding risk by sex act

Understanding risk by sex act From Safer Sex Guide Understanding risk by sex act Kissing (with tongue) Chlamydia Avoid kissing if you or your partners have sores on the lips or mouth, or if one of you has an active oral infection (such

More information

From Safer Sex Guide. Using condoms

From Safer Sex Guide. Using condoms From Safer Sex Guide Using condoms Click to enlarge Using condoms correctly and consistently can signifiantly reduce your chances of passing or getting HIV and other STIs. There are two types of condoms

More information

Detailed results from the START study

Detailed results from the START study From TreatmentUpdate 210 Detailed results from the START study Researchers in 35 countries across all continents collaborated to recruit 4,685 HIV-positive adults who were in good health for START. Upon

More information

Northern Alberta preventing HIV transmission to babies

Northern Alberta preventing HIV transmission to babies CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Northern Alberta preventing HIV transmission to babies 25 June 2009 Since 1996 the widespread availability of combination therapy for HIV

More information

Study finds PEP not 100% effective in preventing HIV infection

Study finds PEP not 100% effective in preventing HIV infection From TreatmentUpdate 152 Study finds PEP not 100% effective in preventing HIV infection Some doctors and nurses who care for PHAs may sustain needle-stick injuries. This raises the possibility that they

More information

Exploring the risks of liver cancer after successful treatment for hepatitis C virus

Exploring the risks of liver cancer after successful treatment for hepatitis C virus CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Exploring the risks of liver cancer after successful treatment for hepatitis C virus 11 June 2013 In Canada and other high-income countries,

More information

Viral infections Hep C and HIV linked to hip fractures

Viral infections Hep C and HIV linked to hip fractures CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Viral infections Hep C and HIV linked to hip fractures 22 November 2012 Infection with hepatitis C virus (HCV) and HIV causes inflammation,

More information

Patient navigators for hepatitis C patients found useful in New York City

Patient navigators for hepatitis C patients found useful in New York City CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Patient navigators for hepatitis C patients found useful in New York City 4 January 2017 Hepatitis C virus (HCV) infects and injures the

More information

Long-acting drugs for HIV

Long-acting drugs for HIV From TreatmentUpdate 222 Long-acting drugs for HIV Long-acting formulations of two anti-hiv drugs are being tested in clinical trials: cabotegravir an experimental integrase inhibitor made available in

More information

Hepatitis C treatment program improves access to housing, income and healthcare

Hepatitis C treatment program improves access to housing, income and healthcare CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Hepatitis C treatment program improves access to housing, income and healthcare 13 July 2015 Despite high rates of hepatitis C virus (HCV)

More information

The debut of velpatasvir for hepatitis C

The debut of velpatasvir for hepatitis C CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. The debut of velpatasvir for hepatitis C 23 November 2015 Hepatitis C virus (HCV) can be grouped into six major strains, or genotypes,

More information

Doravirine vs. darunavir

Doravirine vs. darunavir From TreatmentUpdate 220 Doravirine vs. darunavir Doravirine is an experimental non-nuke that is undergoing phase III clinical trials. It is designed to be effective against most strains of HIV that are

More information

The epidemiology of hepatitis C in Canada

The epidemiology of hepatitis C in Canada The epidemiology of hepatitis C in Canada FACT SHEET Published 2017 This fact sheet provides a snapshot of the hepatitis C epidemic in Canada. It is one of a series of fact sheets providing epidemiological

More information

Here are some of the steps (greatly simplified) and gaps that can occur in the HIV Treatment Cascade:

Here are some of the steps (greatly simplified) and gaps that can occur in the HIV Treatment Cascade: CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Alberta Reducing deaths by strengthening the HIV Treatment Cascade 20 May 2014 In Canada and other high-income countries, deaths from AIDS-related

More information

Does syphilis affect HIV in the brain?

Does syphilis affect HIV in the brain? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Does syphilis affect HIV in the brain? 1 February 2011 Outbreaks of sexually transmitted infections (STIs) are occurring in Canada and

More information

Key messages on hepatitis A for clients are available at the end of this fact sheet.

Key messages on hepatitis A for clients are available at the end of this fact sheet. Hepatitis A Summary Hepatitis A is an infection caused by a virus that can be sexually transmitted. Infection with hepatitis A results in inflammation of the liver (hepatitis). Hepatitis A is transmitted

More information

A study about switching from TDF to TAF

A study about switching from TDF to TAF From TreatmentUpdate 211 A study about switching from TDF to TAF Researchers enrolled HIV-positive participants who were taking regimens containing TDF (tenofovir disoproxil fumarate), the original formulation

More information

Norwegian HIV vaccine Very modest results seen in recent clinical trial

Norwegian HIV vaccine Very modest results seen in recent clinical trial CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Norwegian HIV vaccine Very modest results seen in recent clinical trial 21 February 2012 Although HIV infection can be treated with combination

More information

How are testing technologies used to diagnose HIV infection?

How are testing technologies used to diagnose HIV infection? HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including where the test is conducted,

More information

Hepatitis A FACTSHEET. Summary. What is hepatitis A?

Hepatitis A FACTSHEET. Summary. What is hepatitis A? FACTSHEET Hepatitis A Summary Hepatitis A is an infection caused by a virus that can be sexually transmitted. Infection with hepatitis A results in inflammation of the liver (hepatitis). Hepatitis A is

More information

Increased risk for dialysis found with HIV infection

Increased risk for dialysis found with HIV infection CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Increased risk for dialysis found with HIV infection 12 September 2013 In high-income countries such as Canada, Australia and the U.S.

More information

The epidemiology of HIV in Canada

The epidemiology of HIV in Canada FACTSHEET The epidemiology of HIV in Canada This fact sheet provides a snapshot of the HIV epidemic in Canada. It is one of a series of fact sheets on the epidemiology of HIV and hepatitis C in Canada.

More information

Study explores risk for shingles in the current era

Study explores risk for shingles in the current era CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Study explores risk for shingles in the current era 19 February 2015 Infection with VZV (varicella zoster virus), a member of the herpes

More information

Post-exposure prophylaxis (PEP)

Post-exposure prophylaxis (PEP) Post-exposure prophylaxis (PEP) Summary Post-exposure prophylaxis, or PEP, is a way to help prevent the transmission of HIV in an HIV-negative person who may have been recently exposed to HIV. It involves

More information

Staph Infection Fact Sheet

Staph Infection Fact Sheet What is Staphylococcus aureus (staph)? Staphylococcus aureus, often referred to simply as staph, are bacteria commonly carried on the skin or in the nose of healthy people. Approximately 25% to 30% of

More information

It is a good idea for anyone having sex to get tested regularly and treated for STIs if necessary.

It is a good idea for anyone having sex to get tested regularly and treated for STIs if necessary. FACTSHEET Sexually Transmitted Infections and HIV Transmission This is one of a series of fact sheets about the biology of HIV transmission. The fact sheets review specific biological factors that make

More information

HIV testing technologies

HIV testing technologies HIV testing technologies HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including

More information

American Academy of Pediatrics issues statement on infant feeding and HIV transmission

American Academy of Pediatrics issues statement on infant feeding and HIV transmission CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. American Academy of Pediatrics issues statement on infant feeding and HIV transmission 7 February 2013 The widespread availability of potent

More information

Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP)

Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP) From TreatmentUpdate 197 Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP) The idea of Treatment as Prevention, or TasP, has been proposed and is being implemented in some regions

More information

Study finds sustained-release dexamfetamine is promising for reducing cocaine use

Study finds sustained-release dexamfetamine is promising for reducing cocaine use CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Study finds sustained-release dexamfetamine is promising for reducing cocaine use 27 April 2016 Depending on the circumstances, the use

More information

Is there a link between niacin and stroke?

Is there a link between niacin and stroke? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Is there a link between niacin and stroke? 7 July 2011 A large American-Canadian study called Aim-High was halted 18 months ahead of schedule.

More information

Can mirtazapine assist recovery from crystal meth addiction?

Can mirtazapine assist recovery from crystal meth addiction? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Can mirtazapine assist recovery from crystal meth addiction? 20 December 2011 Stimulants such as amphetamine and its more potent form,

More information

HIV and the immune system linked to heart disease in women

HIV and the immune system linked to heart disease in women CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. HIV and the immune system linked to heart disease in women 26 September 2013 The widespread availability of potent combination anti-hiv

More information

Tuberculosis FACT SHEET. Summary. What is TB?

Tuberculosis FACT SHEET. Summary. What is TB? Tuberculosis Summary Tuberculosis (TB) is caused by bacteria called Mycobacterium tuberculosis complex and usually affects the lungs. However, among people co-infected with TB and HIV, parts of the body

More information

Hep C treatment can cure a person from Hep C. However, a person could get infected again.

Hep C treatment can cure a person from Hep C. However, a person could get infected again. Sofosbuvir (Sovaldi) Summary Sofosbuvir is a medication used to treat Hep C. It is used in combination with other medications to cure people of the Hep C virus. Sofosbuvir is taken at a dose of 400 mg

More information

Tuberculosis FACTSHEET. Summary. What is TB?

Tuberculosis FACTSHEET. Summary. What is TB? FACTSHEET Tuberculosis Summary Tuberculosis (TB) is caused by bacteria called Mycobacterium tuberculosis complex and usually affects the lungs. However, among people co-infected with TB and HIV, parts

More information

Pre-exposure prophylaxis (PrEP)

Pre-exposure prophylaxis (PrEP) FACTSHEET Pre-exposure prophylaxis (PrEP) Summary Pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of becoming infected with HIV.

More information

Hepatitis C Basics. Michael Bailey Director of Programming, CATIE. Mary Choy Regional Health Education Coordinator, CATIE

Hepatitis C Basics. Michael Bailey Director of Programming, CATIE. Mary Choy Regional Health Education Coordinator, CATIE Hepatitis C Basics Michael Bailey Director of Programming, CATIE Mary Choy Regional Health Education Coordinator, CATIE CATIE Our History Learning Objectives 1) To learn about the basics of hepatitis C

More information

MRSA. and You. A Guide for You and Your Family. (Methicillin Resistant Staphylococcus aureus) CH-IPC 001

MRSA. and You. A Guide for You and Your Family. (Methicillin Resistant Staphylococcus aureus) CH-IPC 001 MRSA (Methicillin Resistant Staphylococcus aureus) and You A Guide for You and Your Family CH-IPC 001 12 What is MRSA? MRSA is a kind of staph germ (Staphylococcus aureus). Staph germs live on the skin

More information

Starting points. living with HIV

Starting points. living with HIV Starting points living with HIV Have you found out you have HIV and are trying to get your bearings? We can help you with the basics of living with HIV. Here s what you ll read about in this booklet: What

More information

Programming Connection

Programming Connection The H.E.R. Pregnancy Program Programming Connection Case Study Organization: Streetworks Region: Edmonton, Alberta Prepared: 2018 Quick Facts Population Street involved, Women Date Started 2011 Region

More information

THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention

THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention THE POWER OF UNDETECTABLE What you need to know about HIV treatment as prevention CONTENTS 3 Treatment as prevention First, a few basics: What is an undetectable viral load? How do I know if I m undetectable?

More information

MG an emerging sexually transmitted infection

MG an emerging sexually transmitted infection CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. MG an emerging sexually transmitted infection 9 October 2013 The bacterium Mycoplasma genitalium (MG) is sexually transmitted and can cause

More information

HPV, anal dysplasia and anal cancer

HPV, anal dysplasia and anal cancer HPV, anal dysplasia and anal cancer Summary Anal cancer typically develops over a period of years, beginning with a precancerous condition called anal dysplasia. Anal dysplasia occurs when clusters of

More information

Can metformin also protect arteries?

Can metformin also protect arteries? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Can metformin also protect arteries? 8 December 2011 Reports suggest that cardiovascular disease is becoming common among HIV-positive

More information

Raltegravir (Isentress)

Raltegravir (Isentress) Raltegravir (Isentress) Summary Raltegravir is a type of anti-hiv drug called an integrase inhibitor. Raltegravir is generally well tolerated. Common side effects include diarrhea, nausea and headache;

More information

Does tenofovir (TDF) cause liver injury?

Does tenofovir (TDF) cause liver injury? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Does tenofovir (TDF) cause liver injury? 10 February 2016 Tenofovir is an important antiviral drug used to treat HIV and hepatitis B virus

More information

3TC (lamivudine, Epivir)

3TC (lamivudine, Epivir) 3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes few side

More information

The Patient as Partner

The Patient as Partner From The Positive Side, Summer 2018 The Patient as Partner The idea that a person should be an active participant, not just a recipient, of their own healthcare has deep roots. Feminists, people living

More information

Methicillin-Resistant Staphylococcus aureus (MRSA) in schools and among athletes

Methicillin-Resistant Staphylococcus aureus (MRSA) in schools and among athletes Methicillin-Resistant Staphylococcus aureus (MRSA) in schools and among athletes Frequently asked questions What is Staphylococcus aureus?...2 What is Methicillin Resistant Staphylococcus aureus (MRSA)?...2

More information

Key messages on chlamydia for clients are available at the end of this fact sheet.

Key messages on chlamydia for clients are available at the end of this fact sheet. Chlamydia Summary Chlamydia is a sexually transmitted infection caused by a bacterium. It can be transmitted through sexual contact. All people who are sexually active may be at risk for chlamydia. Chlamydia

More information

Bloodborne Pathogen Safety Awareness Including information regarding MRSA

Bloodborne Pathogen Safety Awareness Including information regarding MRSA Bloodborne Pathogen Safety Awareness Including information regarding MRSA Presented by the Department of Environmental Health, Safety & Risk Management Bloodborne Pathogens Bloodborne Pathogens are microorganisms

More information

Community Associated MRSA: Prevention and Control in Athletes. Wisconsin Wrestling Coaches Association November 3, 2007

Community Associated MRSA: Prevention and Control in Athletes. Wisconsin Wrestling Coaches Association November 3, 2007 Community Associated MRSA: Prevention and Control in Athletes Wisconsin Wrestling Coaches Association November 3, 2007 What is Staphylococcus aureus? staph Bacterium Lives on skin or in nose of healthy

More information

HPV, Cervical Dysplasia and Cancer

HPV, Cervical Dysplasia and Cancer FACTSHEET HPV, Cervical Dysplasia and Cancer Summary Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions by doctors, may persist and

More information

INFECTION CONTROL: MRSA AND OTHER RESISTANT GERMS

INFECTION CONTROL: MRSA AND OTHER RESISTANT GERMS INFECTION CONTROL: MRSA AND OTHER RESISTANT GERMS Objectives: At the end of this class, you will be able to: 1. Discuss the difference between bacteria and viruses. 2. Explain why some antibiotics no longer

More information

Quad (Stribild) Safety and effectiveness issues in depth

Quad (Stribild) Safety and effectiveness issues in depth From TreatmentUpdate 191 Quad (Stribild) Safety and effectiveness issues in depth The FDA reviewed health-related information collected from 1,408 HIV-positive people who participated in two pivotal clinical

More information

The HIV testing process

The HIV testing process FACTSHEET The HIV testing process Summary There are a few steps that a person will take in the HIV testing process. To access an HIV test, people can request a test or may be offered a test. There are

More information

Hepatitis B FACTSHEET. Summary

Hepatitis B FACTSHEET. Summary FACTSHEET Hepatitis B Summary Hepatitis B is an infection caused by a virus that can be transmitted by sexual exposure to blood or bodily fluids, injection drug use, and household contact with someone

More information

Hepatitis C virus some background information

Hepatitis C virus some background information From TreatmentUpdate 167 Hepatitis C virus some background information Hepatitis C virus (HCV) is spread by exposure to infected blood. The following behaviours, which can expose a person to infected blood,

More information

Information on Staphylococcal Infections For Day Care Administrators and Care Givers

Information on Staphylococcal Infections For Day Care Administrators and Care Givers Information on Staphylococcal Infections For Day Care Administrators and Care Givers Antibiotic resistant-bacteria currently pose a significant health threat. A person in your daycare facility may have

More information

Hepatitis B FACTSHEET. Summary

Hepatitis B FACTSHEET. Summary FACTSHEET Hepatitis B Summary Hepatitis B is an infection caused by a virus that can be transmitted by sexual exposure to blood or bodily fluids, injection drug use, and household contact with someone

More information

Antiviral medications can reduce the severity and frequency of genital herpes outbreaks.

Antiviral medications can reduce the severity and frequency of genital herpes outbreaks. Genital herpes Summary Genital herpes is a sexually transmitted infection caused by the herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). Once a person is infected with HSV, the virus stays in the

More information

Harvoni (ledipasvir + sofosbuvir)

Harvoni (ledipasvir + sofosbuvir) Harvoni (ledipasvir + sofosbuvir) Summary Harvoni is a medication used to treat hepatitis C. It is approved in Canada for people with all genotypes of the hepatitis C virus. Harvoni is a combination of

More information

Lymphoma FACTSHEET. Summary. About the lymphatic system. Who is at risk for lymphoma? What is lymphoma?

Lymphoma FACTSHEET. Summary. About the lymphatic system. Who is at risk for lymphoma? What is lymphoma? FACTSHEET Lymphoma Summary Lymphoma is a cancer that affects a part of the immune system called the lymphatic system. Like any cancer, the earlier lymphoma is diagnosed, the easier it is to treat. In general,

More information

Daclatasvir (Daklinza)

Daclatasvir (Daklinza) Daclatasvir (Daklinza) Summary Daclatasvir (Daklinza) is a medication used to treat hepatitis C. It is taken with sofosbuvir (Sovaldi) and sometimes ribavirin. This combination is approved in Canada for

More information

Crystal meth interviews reveal its impact on HIV positive men

Crystal meth interviews reveal its impact on HIV positive men CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Crystal meth interviews reveal its impact on HIV positive men 15 April 2009 Crystal meth, also known as ice or Tina, is a form of the stimulant

More information

Harvoni (ledipasvir + sofosbuvir)

Harvoni (ledipasvir + sofosbuvir) FACTSHEET Harvoni (ledipasvir + sofosbuvir) Summary Harvoni is a medication used to treat hepatitis C. It is approved in Canada for people with genotype 1 hepatitis C virus. Harvoni is a combination of

More information

HIV treatment and an undetectable viral load to prevent HIV transmission

HIV treatment and an undetectable viral load to prevent HIV transmission HIV treatment and an undetectable viral load to prevent HIV transmission FACT SHEET Published 2018 CONTACT US Summary It is now well known that the use of HIV treatment not only improves the health of

More information

MRSA: Implications in Sports Medicine

MRSA: Implications in Sports Medicine MRSA: Implications in Sports Medicine Staphylococcus aureus, often referred to as staph, are bacteria commonly carried on the skin or in the nose of healthy people Staphylococcus Aureus Occasionally, staph

More information

Methicillin-resistant Staphylococcus aureus for Athletes What YOU Need to Know

Methicillin-resistant Staphylococcus aureus for Athletes What YOU Need to Know Methicillin-resistant Staphylococcus aureus for Athletes What YOU Need to Know Methicillin-Resistant Staphylococcus aureus (MRSA) Outbreaks of skin infections caused by Staphylococcus aureus resistant

More information

FAMILY LIFE Education. Fifth Grade Instructional lessons

FAMILY LIFE Education. Fifth Grade Instructional lessons FAMILY LIFE Education Fifth Grade Instructional lessons As new and updated videos and instructional materials become available the Family Life Supervisor may include them where appropriate without altering

More information

Reducing Your Infections

Reducing Your Infections For People With HIV... Reducing Your Risk for Other Infections When is your body at risk for an opportunistic infection? Visit us online at www.patienteducationcenter.org Good News! T he number of people

More information

3TC (lamivudine, Epivir)

3TC (lamivudine, Epivir) FACTSHEET 3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes

More information

Exciting results in monkeys lead to a clinical trial in humans

Exciting results in monkeys lead to a clinical trial in humans From TreatmentUpdate 219 Exciting results in monkeys lead to a clinical trial in humans A close relative of HIV called SIV (simian immunodeficiency virus) causes an AIDS-like disease in susceptible monkeys.

More information

Bloodborne Pathogens. Aaron Holmberg, Risk Manager. ARM, MBA, OSHA Authorized Outreach Trainer February 2018

Bloodborne Pathogens. Aaron Holmberg, Risk Manager. ARM, MBA, OSHA Authorized Outreach Trainer February 2018 Bloodborne Pathogens Aaron Holmberg, Risk Manager ARM, MBA, OSHA Authorized Outreach Trainer February 2018 What s This About? Infectious microorganisms (viruses and diseases) found in blood and bodily

More information

IMPORTANT THINGS TO KNOW WHEN YOU HAVE HEPATITIS C

IMPORTANT THINGS TO KNOW WHEN YOU HAVE HEPATITIS C IMPORTANT THINGS TO KNOW WHEN YOU HAVE HEPATITIS C GETTING STARTED: Important things to know when you have hepatitis C If you just found out that you have hepatitis C, you may have a lot of questions.

More information

February

February February 2009 www.srhd.org For more copies or if you have questions, contact: Spokane Regional Health District Disease Prevention & Response (509) 324-1442 or TDD (509) 324-1464 This booklet uses information

More information

Staph Infections. including MRSA

Staph Infections. including MRSA Staph Infections including MRSA What is a Staph infection? STAPH Staphylococcus aureus, often referred to simply as staph, are bacteria commonly carried on the skin or in the nose of healthy people. SYMPTOMS

More information

HPV, cervical dysplasia and cervical cancer

HPV, cervical dysplasia and cervical cancer HPV, cervical dysplasia and cervical cancer FACT SHEET Published 2016 Summary Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions

More information

MRSA. (Methicillin-resistant Staphylococcus aureus) Patient & Family Guide.

MRSA. (Methicillin-resistant Staphylococcus aureus) Patient & Family Guide. Patient & Family Guide MRSA 2017 (Methicillin-resistant Staphylococcus aureus) Aussi disponible en français : SARM (Staphylococcus aureus résistant à la méthicilline) (FF85-1858) www.nshealth.ca MRSA (Methicillin-resistant

More information

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another? Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another? HIV transmission can occur when blood, semen (including pre-seminal fluid or "pre-cum"),

More information

MRSA The Facts. Staphylococcus aureus MRSA. Staphylococcus aureus, often referred to simply as "staph," What is Staphylococcus aureus?

MRSA The Facts. Staphylococcus aureus MRSA. Staphylococcus aureus, often referred to simply as staph, What is Staphylococcus aureus? MRSA SOME FACTS This leaflet is written to provide information to anyone who may be going to use the health service in Glasgow and Clyde or who just wishes to know more about Meticillin resistant Staphylococcus

More information

Daclatasvir (Daklinza)

Daclatasvir (Daklinza) FACTSHEET Daclatasvir (Daklinza) Summary Daclatasvir (Daklinza) is a medication used to treat hepatitis C. It is taken with sofosbuvir (Sovaldi) and sometimes ribavirin. This combination is approved in

More information

Teacher Resource: Anecdotal Recording Chart. Class: Specific Expectations: Success Criteria: (Page 1 of 2) Student Name. Observation.

Teacher Resource: Anecdotal Recording Chart. Class: Specific Expectations: Success Criteria: (Page 1 of 2) Student Name. Observation. Teacher Resource: Anecdotal Recording Chart (Page 1 of 2) Class: Specific Expectations: Success Criteria: Student Name Observation Student Name Observation Student Name Observation Teacher Resource: Anecdotal

More information

STI s. (Sexually Transmitted Infections)

STI s. (Sexually Transmitted Infections) STI s (Sexually Transmitted Infections) Build Awareness In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise. One of the primary defenses in the fight

More information

This program will outline infection prevention measures known to help reduce the risk of patients getting a healthcare associated infection (HAI).

This program will outline infection prevention measures known to help reduce the risk of patients getting a healthcare associated infection (HAI). This program will outline infection prevention measures known to help reduce the risk of patients getting a healthcare associated infection (HAI). Hand Hygiene Spread the Word.. Not the Germs.. Clean

More information

How is it transferred?

How is it transferred? STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live

More information

Will de-simplification of HIV treatment become common in highincome

Will de-simplification of HIV treatment become common in highincome CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Will de-simplification of HIV treatment become common in highincome countries? 13 February 2018 As more people start HIV treatment, researchers

More information

YOUR SEASONAL FLU GUIDE

YOUR SEASONAL FLU GUIDE YOUR SEASONAL FLU GUIDE b What is the seasonal flu? b What can you do to prevent the seasonal flu? b Resources WWW.FIGHTFLU.CA To promote and protect the health of Canadians through leadership, partnership,

More information

Informational Awareness

Informational Awareness Informational Awareness What is MRSA? MRSA is a kind of Staphylococcus aureus ( staph ) bacterium that is resistant to betalactam antibiotics, including methicillin, oxacillin, penicillin, and amoxicillin.

More information

Gonorrhea Shrinking treatment options

Gonorrhea Shrinking treatment options CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Gonorrhea Shrinking treatment options 31 March 2011 Gonorrhea is a relatively common infection among men who have sex with men, but it

More information

NHS GG&C Public Health Protection Unit (PHPU)/ Infection Control Policy. For investigation and management of PVL SA

NHS GG&C Public Health Protection Unit (PHPU)/ Infection Control Policy. For investigation and management of PVL SA Page 1 of 16 NHS GG&C Public Health Protection Unit (PHPU)/ Infection Control Policy For investigation and management of PVL SA Document Control Summary Approved by and date Date of Publication Developed

More information

Schizophrenia and HIV Study underscores serious issues associated with dual diagnoses

Schizophrenia and HIV Study underscores serious issues associated with dual diagnoses CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Schizophrenia and HIV Study underscores serious issues associated with dual diagnoses 15 July 2015 Several studies have found that some

More information

The elusive AIDS vaccine

The elusive AIDS vaccine CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. The elusive AIDS vaccine 4 March 2008 In the 25 years since HIV was discovered, researchers have made many strides in the fight against

More information

How to Prevent Sexually Transmitted Diseases

How to Prevent Sexually Transmitted Diseases ACOG publications are protected by copyright and all rights are reserved. ACOG publications may not be reproduced in any form or by any means without written permission from the copyright owner. This includes

More information

I ANTI-HIV AGENTS. Contents I ANTI-HIV AGENTS II COMPLICATIONS AND SIDE EFFECTS. A. Raltegravir vs. efavirenz four. years later

I ANTI-HIV AGENTS. Contents I ANTI-HIV AGENTS II COMPLICATIONS AND SIDE EFFECTS. A. Raltegravir vs. efavirenz four. years later TreatmentUpdate 179 Vol. 22, No. 4 May/June 2010 ISSN 11817187 Available on the World Wide Web at www.catie.ca/tu.nsf Contents I ANTI-HIV AGENTS A. Raltegravir vs. efavirenz four years later 1 B. Raltegravir

More information

STI & HIV PRE-TEST ANSWER KEY

STI & HIV PRE-TEST ANSWER KEY Name: STI & HIV PRE-TEST ANSWER KEY 1. You can catch a STI or HIV from door knobs, toilet seats, or FALSE drinking fountains. STIs are transmitted sexually, requiring sexual contact. Some STIs can be transmitted

More information

HealthStream Regulatory Script

HealthStream Regulatory Script HealthStream Regulatory Script [Transmission-Based Precautions: Contact and Droplet] Version: [April 2005] Lesson 1: Introduction Lesson 2: Contact Precautions Lesson 3: Droplet Precautions Lesson 1: Introduction

More information